Although stapled anopexy for second and third degree hemorrhoids has been widely used since 1998, there are limited long-term data available. We performed an analysis of a prospectively accrued data set of all patients undergoing stapled anopexy in our practice from 1998 through August 2003. Patients were specifically assessed for early and late complications and long-term reoperation rates for anorectal pathology. We performed stapled anopexy in 654 patients (296 females) during the study period. Mean operation time was 21 min (5-70 min), and the postoperative stay was 3.6 days (1-13 days). Early postoperative complications: urinary retention, 42 patients (6.4%); fecal impaction, 18 (2.8%); postoperative hemorrhage, 26 (4.0%); thrombosed external hemorrhoid, four (0.6%); and fistula/abscess, nine (1.4%). Late postoperative complications: anastomotic dehiscence, 21 patients (3.2%); persistence of prolapse in three (0.5%); submucosal anastomotic cysts in four (0.6%); thrombosed external hemorrhoid in two (0.3%); skin tags in ten (1.5%); fissure in six (0.9%); proctitis in two (0.3%); and fecal incontinence in ten (1.5%). Reoperation was required in 50 patients (7.6%). Reoperation for complications within 30 days occurred in 42 patients (6.4%) for the following reasons: bleeding (23), dehiscence (five), thrombosed external hemorrhoid (three), fecal retention (two), fistula (three), fissure (five), and anal papilla (one). Reoperation for anorectal pathology after 30 days was required in 54 patients (8.3%) and was performed for the following: dehiscence/reprolapse (17), stenosis (two), submucous cyst (two), fistula (four), fissure (six), anal papilla (four), skin tags (five), persistent anal itching (five), and miscellaneous (seven). These data represent the largest series of patients with long-term follow-up following stapled anopexy and confirm that the operation is safe in experienced hands using appropriate patient selection. The early complication rate is low and similar to rates reported for excisional hemorrhoidectomy. Importantly, the procedure is associated with a low 3.4% rate of reoperation for persistence or recurrence of hemorrhoidal prolapse with good patient selection.
Perianal streptococcal dermatitis is an infectious disease that predominantly affects younger children and is mostly caused by Group A beta-hemolytic streptococci. Although patients are mostly seen primarily by their pediatrician or family physician, the diagnosis is not infrequently established just after referral to a dermatologist or colorectal surgeon. We report a case series of 124 children, aged 14 years or younger, who were seen at our office for anorectal complaints between February 2003 and September 2006. Twenty-one of 124 patients (16 percent) were diagnosed with perianal streptococcal dermatitis on the basis of a positive perianal swab by microbiologic analysis. Perianal streptococcal dermatitis was the most frequent infectious disease in that age group in our practice. Sixteen (of 21, 76 percent) patients were male, and the mean age was 6.3 years. One course of systemic antibiotic treatment augmented by additional local antiseptic ointment in selected cases cured all patients within 10 to 14 days. One patient presented with a new perianal streptococcal dermatitis episode five months after treatment and was successfully retreated with an oral antibiotic. With this report, we wish to alert the colorectal community of the diagnosis because it may be underdiagnosed in our practices and thereby lead to prolonged discomfort, protracted disease, and potentially harmful sequelae for these typically very young patients.
Reoperations after SH are necessary in about 10% of the patients. The majority of the reoperations are due to either complications arising from circular SH, recurrent/persistent haemorrhoidal symptoms or other anorectal issues not addressed by the circular SH procedure (3.8% early; 6.8% late). Circular SH appears to be an effective procedure for symptomatic haemorrhoidal disease; however, training and learning curve issues should be addressed to minimise treatment failures.
ZusammenfassungHintergrund und Ziel: Die Analvenenthrombose (AVT) ist einer der häufigsten proktologischen Notfälle. Sie verursacht Schmerzen, die die Patienten zum Arzt führen. Die Behandlung wird sowohl konservativ als auch operativ durchgeführt. Ziel der Studie war es, die Unterschiede zwischen operativer und konservativer Therapie der AVT festzustellen. Patienten undMethodik: Retrospektiv wurden alle Patienten mit AVT, die 2005 operativ oder konservativ (Salbe und/oder nichtsteroidale Antirheumatika [NSAR]) behandelt wurden, untersucht. Operation: in Lokalanästhesie Exzision des Befundes, offene Wundbehandlung. Konservative Therapie: lokale Behandlung mit kortikosteroidhaltiger Salbe und/oder oraler antiphlogistischer Therapie (NSAR). Die Patienten erhielten 2006/2007 einen Fragebogen mit Fragen nach Rezidiveingriffen, Rezidiv-AVT, aktuellen anorektalen Beschwerden und Zufriedenheit des Patienten mit der durchgeführten Therapie der AVT. Ergebnisse: 2005 wurden 142 Patienten (72 Männer, 70 Frauen, medianes Alter 49 Jahre) wegen AVT behandelt. 86 Patienten wurden konservativ, 56 operativ behandelt. Rezidive: konservative Gruppe 14 (12,5%), operative Gruppe drei (5,4%). Abszess nach Operation bei einem Patienten (1,8%). Rücklaufquote der Fragebögen und Nachbeobachtungszeit: konservative Gruppe 63,4%, 22 Monate; operative Gruppe 73,2%, 16 Monate. Beschwerden: Nach konservativer Therapie klagten Patienten vermehrt, wenn auch nicht signifikant, über Nässen, Schwellung, Blutung und Schmerz als Patienten nach Operation. Aus der Gruppe der operierten Patienten würden sich mehr Patienten wieder mit derselben Methode behandeln lassen (87,8%) als aus der konservativen Gruppe (63%).Schlussfolgerung: Die operative wie auch die konservative Therapie der AVT sind komplikationsarm und effektiv. Obwohl die Patientenzufriedenheit mit der operativen Therapie größer ist als mit der konservativen Therapie, zeigten sich bei den analen Beschwerden in der Nachuntersuchung keine Unterschiede zwischen den Gruppen. Schlüsselwörter: Analvenenthrombose · Perianalthrombose · Hämorrhoiden · Operative Therapie · Konservative Therapie coloproctology 2009;31:93-8 coloproctology Originalarbeit Jongen J, et al. Therapie der Analvenenthrombose 94 coloproctology 31 · 2009 · Nr. 2 AbstractBackground and Purpose: Thrombosed external hemorrhoid (TEH) is probably the most frequent anorectal emergency. It causes pain that brings the patient to his/her physician or to the emergency room. Treatment may be medical, but also surgical. The aim of this study was to determine differences between surgical and medical (nonsurgical) therapy of TEH.
Proktitis ist eine Entzündung des Rektums und geht mit völlig unspezifischen Symptomen wie transanalen Blutungen, häufigem Stuhldrang (Tenesmen), Schleimbeimischungen, Schmerzen usw. einher. Die Proktitis kann unterschiedliche Ursachen haben. In diesem Beitrag werden die infektiösen Ursachen wie die sexuell übertragbaren Krankheiten oder Infektionen (STD oder STI, Herpes, Chlamydien, Gonorrhö usw.) und die spezifischen chronisch-entzünd-lichen Darmerkrankungen (CED, Morbus Crohn, Colitis ulcerosa), die auch mit einer Proktitis einhergehen können, nicht abgehandelt. Im Folgenden werden zunächst die Symptome, Befunde und Differenzialdiagnostik besprochen. Anschließend werden die häufigsten Ursachen für "proktologische" Proktitiden in aufsteigender Reihenfolge ihrer Häu-figkeit in der Praxis abgehandelt (externe Agenzien eher selten, radiogen bedingte Proktitis am häufigsten). Proktitis aus Sicht der Proktologie Übersichtsarbeit Abb. 1 7 Rektales Ulkus nach Abusus von Suppositorien mit Paracetamol und Codein 273 coloproctology 5 · 2010 |
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.